Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). (Q43945108)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). |
scientific article |
Statements
1 reference
Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). (English)
1 reference
Michael A Pfaller
1 reference
Ronald N Jones
1 reference
Jan M Bell
1 reference
John D Turnidge
1 reference
Sentry APAC Study Group
1 reference
1 March 2002
1 reference
1 reference
Identifiers
1 reference